INOVIO PHARMACEUTICALS, INC. Line of Credit Facility, Increase, Accrued Interest
INOVIO PHARMACEUTICALS, INC. (INO) reported Line of Credit Facility, Increase, Accrued Interest of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-15.
Discontinued › Notes › Debt
us-gaap:LineOfCreditFacilityIncreaseAccruedInterest · last filed 2017-03-15
- INOVIO PHARMACEUTICALS, INC. line of credit facility, increase, accrued interest for the quarter ending 2015-12-31 was $0.00.
- INOVIO PHARMACEUTICALS, INC. line of credit facility, increase, accrued interest for the quarter ending 2014-12-31 was $0.00.
- INOVIO PHARMACEUTICALS, INC. line of credit facility, increase, accrued interest for the quarter ending 2010-12-31 was $0.00.
- INOVIO PHARMACEUTICALS, INC. line of credit facility, increase, accrued interest for the quarter ending 2010-09-30 was -$330.00.
- INOVIO PHARMACEUTICALS, INC. line of credit facility, increase, accrued interest for fiscal 2016 was $0.00.
- INOVIO PHARMACEUTICALS, INC. line of credit facility, increase, accrued interest for fiscal 2015 was $0.00.
- INOVIO PHARMACEUTICALS, INC. line of credit facility, increase, accrued interest for fiscal 2014 was -$57.19K.
- INOVIO PHARMACEUTICALS, INC. line of credit facility, increase, accrued interest for fiscal 2013 was $0.00.
| Period end | Line of Credit Facility, Increase, Accrued Interest 3 month | Line of Credit Facility, Increase, Accrued Interest 6 month | Line of Credit Facility, Increase, Accrued Interest 9 month | Line of Credit Facility, Increase, Accrued Interest 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-15 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 10-K · filed 2017-03-15 | ||
| 2015-09-30 | $0.00 10-Q · filed 2015-11-09 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | -$57.19K 10-K · filed 2017-03-15 | ||
| 2014-09-30 | -$57.19K 10-Q · filed 2015-11-09 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-03-14 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-03-16 | |||
| 2011-12-31 | $0.00 10-K · filed 2013-03-18 | |||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$330.00 derived: sum of 2 quarters · filed 2013-03-18 | -$61.15K 10-K · filed 2013-03-18 | |
| 2010-09-30 | -$330.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | -$61.15K 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | -$60.82K 10-Q · filed 2011-08-05 | |||
| 2009-12-31 | -$166.18K 10-K · filed 2012-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |